Explainer-Who is eligible for the new FDA-approved Alzheimer’s drug?

By Deena Beasley The U.S. Food and Drug Administration on Thursday granted standard approval to Eisai and Biogen’s Leqembi for patients with Alzheimer’s disease. The FDA decision is expected to trigger broader coverage of the $26,500-a-year drug by the U.S. government’s Medicare health plan for people aged 65 and older. Leqembi was granted “accelerated” FDA…

Read More

AbbVie trims full-year profit forecast on higher R&D expenses

(Reuters) -AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development expenses during the second quarter. The company now expects adjusted profit between $10.57 and $10.97 per share, compared with $10.72 to $11.12 it previously expected. Analysts on average were expecting full-year earnings of $10.97 per…

Read More

AI robots could play future role as companions in care homes

By Emma Farge GENEVA (Reuters) – Nadine, a social robot powered by Artificial Intelligence (AI) with human-like gestures and expressions, could have an important future role to play in tending to the sick and elderly, according to a professor who helped invent it. Nadia Magnenat Thalmann, a robot expert from the University of Geneva, who…

Read More

Generali buys U.S. asset manager Conning under deal with Cathay Life

MILAN (Reuters) – Generali has agreed to buy Connecticut-based asset manager Conning Holdings as part of a partnership with Cathay Life, a unit of Taiwan’s Cathay Financial Holding, the Italian insurer said on Thursday. The deal, structured as an exchange of assets without a cash consideration, realises Generali CEO Philippe Donnet’s ambition of expanding into…

Read More

Chinese rush to buy Hong Kong insurance, dollars as confidence cracks, yuan weakens

SHANGHAI/HONG KONG (Reuters) – Chinese investors are rushing offshore to make dollar deposits and buy Hong Kong insurance in a signal domestic confidence is languishing and that the ailing yuan faces more pressure. The outflows highlight deep-seated concern about the state of China’s economy as its much-awaited pandemic recovery stalls. Consumer spending is flagging, the…

Read More